Biography of Svetlana Lucas
Last update: March 14, 2024Career
Svetlana was Senior Vice President, Business Development at Tizona Therapeutics, and Head of Oncology and Inflammation at Amgen.
Svetlana Lucas is currently- Chief Business Officer at Scribe Therapeutics - View - Scribe Therapeutics org chart
- Director at aTyr Pharma - View - aTyr Pharma org chart
Create your alert
to follow the career of Svetlana Lucas.
Education
Svetlana Lucas has a undergraduate degree in Biology from Lomonosov Moscow State University and a PhD in Molecular Biology and Biochemistry from California Institute of Technology.
They have also studied at Lomonosov Moscow State University :
Find more alumni from Lomonosov Moscow State University
They have also studied at California Institute of Technology :
Find more alumni from California Institute of Technology
More about Svetlana Lucas
Selected links
Do you need to know more about Svetlana Lucas? More results.
Participate
Social media
- Svetlana Lucas on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Svetlana Lucas
The colleagues of Svetlana Lucas
Company Colleagues
- At Scribe Therapeutics, Svetlana Lucas has 13 colleagues including Benjamin Oakes (CEO & Director), Behzad Aghazadeh (Director)…
- At aTyr Pharma, Svetlana Lucas has 15 colleagues including Sanjay Shukla (CEO & Director), Jane Gross (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Svetlana Lucas has 19,369 colleagues in 1,861 companies located in 69 countries. 8,437 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Svetlana Lucas.
Get in Touch
and ask for Svetlana Lucas.
